After retirement, Caroline happily worked alongside her sons, Doug and Kenny at North American Power Sports. She was the glue that held everything together.

Credit: shisu_ka/Shutterstock. Magnet Biomedicine has entered a partnership and licence agreement with Eli Lilly to discover, develop and commercialise oncology molecular glue therapeutics. The ...

Other pharmas have also put big money into the glue game. In 2024, Eisai signed its own Seed pact worth up to $1.5 billion to go after neurodegeneration and oncology targets.